Key facts
- This page summarizes Poh Chit Laa's Form 3 filing for Alps Group Inc (ALPS).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Mar 2026, 20:57.
Poh Chit Laa - 18 Mar 2026 Form 3 Insider Report for Alps Group Inc (ALPS)
- Reporting relationship
- Chief Vaccine Development Officer
- Issuer ticker
- ALPS
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Poh Chit Laa
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Poh Chit Laa filed Form 3 for Alps Group Inc (ALPS) on 24 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002122760
Primary reporting owner
Poh Chit Laa
- Relationship
- Chief Vaccine Development Officer
- Address
- UNIT E18-01&02, LVL 18, ICON TWR E, NO. 1, JALAN 1/68F, JALAN TUN RAZAK, KUALA LUMPUR, MALAYSIA
- Signature
- /s/ Poh Chit Laa
- Signature date
- 24 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALPS
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,000
- Date
- 18 Mar 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
SEC remarks
Chief Vaccine Development Officer